Spravato is a medication that has been approved by the FDA for the treatment of depression. It is a nasal spray that contains a form of ketamine, which has been shown to be effective in treating depression that has not responded to other treatments. In this article, we will discuss how the PsyFi TMS Spravato treatment works and the science behind it.
The Science behind Spravato
Ketamine is a medication that has been used as an anesthetic for many years. In recent years, it has been shown to have a rapid and profound antidepressant effect, even in patients who have not responded to other treatments. However, the use of ketamine for depression has been limited due to its potential for abuse and the fact that it can cause dissociative and hallucinogenic effects.
Spravato contains a form of ketamine called esketamine. Esketamine is a version of ketamine that has been modified so that it has a lower potential for abuse and fewer dissociative and hallucinogenic effects. Spravato is administered as a nasal spray, which allows for rapid absorption into the bloodstream.
How Spravato Works
The exact mechanism by which Spravato works to treat depression is not fully understood. However, it is thought that esketamine works by increasing the activity of certain neurotransmitters in the brain, including glutamate. Glutamate is a neurotransmitter that is involved in learning and memory, as well as in the regulation of mood.
It is thought that depression may be caused by a decrease in the activity of certain neurotransmitters in the brain, including glutamate. By increasing the activity of glutamate, Spravato may help to restore the balance of neurotransmitters in the brain and improve mood.
Spravato Treatment Process
The Spravato treatment process involves several steps. The first step is to be evaluated by a healthcare provider to determine if Spravato is an appropriate treatment option. Spravato is typically prescribed for patients who have not responded to other treatments for depression.
Once a patient is deemed eligible for Spravato treatment, they will receive the medication as a nasal spray in a healthcare provider’s office or clinic. The healthcare provider will monitor the patient for at least two hours after administration of the medication to ensure that there are no adverse effects.
Patients typically receive Spravato treatment twice a week for the first four weeks, and then once a week for the next four weeks. After the first eight weeks of treatment, we will reassess the patient to determine if further treatment is necessary.
Side Effects of Spravato
Like any medication, Spravato may cause side effects. The most common side effects of Spravato include dizziness, nausea, and feeling disconnected from reality. These side effects typically resolve within a few hours of administration of the medication.
In rare cases, Spravato may cause more serious side effects, including sedation, increased blood pressure, and breathing problems. Patients should be monitored by a healthcare provider for at least two hours after administration of the medication to ensure that there are no serious side effects.
Conclusion
Spravato is a medication that has been shown to be effective in treating depression that has not responded to other treatments. It contains a form of ketamine called esketamine, which has been modified to have a lower potential for abuse and fewer dissociative and hallucinogenic effects.
The exact mechanism by which Spravato works to treat depression is not fully understood, but it is thought to work by increasing the activity of certain neurotransmitters in the brain. Spravato is administered as a nasal spray in a healthcare provider’s office or clinic, and patients are monitored for at least two hours after administration of the medication to ensure that there are no adverse effects. Get in touch with us today at info@psyfitms.com to learn more about our PsyFi TMS Spravato Treatment.
